Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Eli Lilly and Company Stock Price: LLY Closes at $878.24 as Insilico Deal, Trial Data Put Monday in Focus
Eli Lilly’s stock closed at $878.24 after the company announced a significant $2.75 billion licensing and research deal with Insilico Medicine. This comes as Lilly aims to diversify beyond its weight-loss drugs, with new trial data showing positive results for its psoriatic arthritis treatment combination and its eczema drug. The company continues to navigate competition and analyst adjustments to sales estimates for the obesity-drug sector.